148 related articles for article (PubMed ID: 18039001)
1. Hyaluronate-covered nanoparticles for the therapeutic targeting of cartilage.
Laroui H; Grossin L; Léonard M; Stoltz JF; Gillet P; Netter P; Dellacherie E
Biomacromolecules; 2007 Dec; 8(12):3879-85. PubMed ID: 18039001
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of intra-articular delivery of hyaluronic acid functionalized biopolymeric nanoparticles in healthy rat knees.
Zille H; Paquet J; Henrionnet C; Scala-Bertola J; Leonard M; Six JL; Deschamp F; Netter P; Vergès J; Gillet P; Grossin L
Biomed Mater Eng; 2010; 20(3):235-42. PubMed ID: 20930333
[TBL] [Abstract][Full Text] [Related]
3. Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides.
Kumar A; Sahoo B; Montpetit A; Behera S; Lockey RF; Mohapatra SS
Nanomedicine; 2007 Jun; 3(2):132-7. PubMed ID: 17572355
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages.
Kamat M; El-Boubbou K; Zhu DC; Lansdell T; Lu X; Li W; Huang X
Bioconjug Chem; 2010 Nov; 21(11):2128-35. PubMed ID: 20977242
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled hyaluronic acid nanoparticles for active tumor targeting.
Choi KY; Chung H; Min KH; Yoon HY; Kim K; Park JH; Kwon IC; Jeong SY
Biomaterials; 2010 Jan; 31(1):106-14. PubMed ID: 19783037
[TBL] [Abstract][Full Text] [Related]
7. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.
Contreras-Ruiz L; de la Fuente M; García-Vázquez C; Sáez V; Seijo B; Alonso MJ; Calonge M; Diebold Y
Cornea; 2010 May; 29(5):550-8. PubMed ID: 20335805
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
[TBL] [Abstract][Full Text] [Related]
10. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin.
Lee H; Ahn CH; Park TG
Macromol Biosci; 2009 Apr; 9(4):336-42. PubMed ID: 19006195
[TBL] [Abstract][Full Text] [Related]
11. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
de la Fuente M; Seijo B; Alonso MJ
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2016-24. PubMed ID: 18436835
[TBL] [Abstract][Full Text] [Related]
12. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
[TBL] [Abstract][Full Text] [Related]
13. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo.
Choi KY; Min KH; Yoon HY; Kim K; Park JH; Kwon IC; Choi K; Jeong SY
Biomaterials; 2011 Mar; 32(7):1880-9. PubMed ID: 21159377
[TBL] [Abstract][Full Text] [Related]
14. The effect of hyaluronic acid and phospholipid based lubricants on friction within a human cartilage damage model.
Forsey RW; Fisher J; Thompson J; Stone MH; Bell C; Ingham E
Biomaterials; 2006 Sep; 27(26):4581-90. PubMed ID: 16701868
[TBL] [Abstract][Full Text] [Related]
15. Oxygen-derived free radical (ODFR) action on hyaluronan (HA), on two HA ester derivatives, and on the metabolism of articular chondrocytes.
Kvam BJ; Fragonas E; Degrassi A; Kvam C; Matulova M; Pollesello P; Zanetti F; Vittur F
Exp Cell Res; 1995 May; 218(1):79-86. PubMed ID: 7737382
[TBL] [Abstract][Full Text] [Related]
16. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L
J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359
[TBL] [Abstract][Full Text] [Related]
17. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.
Hyung W; Ko H; Park J; Lim E; Park SB; Park YJ; Yoon HG; Suh JS; Haam S; Huh YM
Biotechnol Bioeng; 2008 Feb; 99(2):442-54. PubMed ID: 17625788
[TBL] [Abstract][Full Text] [Related]
18. Cell-specific delivery of polymeric nanoparticles to carbohydrate-tagging cells.
Iwasaki Y; Maie H; Akiyoshi K
Biomacromolecules; 2007 Oct; 8(10):3162-8. PubMed ID: 17883278
[TBL] [Abstract][Full Text] [Related]
19. In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors.
Jain A; Jain SK
Eur J Pharm Sci; 2008 Dec; 35(5):404-16. PubMed ID: 18824095
[TBL] [Abstract][Full Text] [Related]
20. Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage.
Rothenfluh DA; Bermudez H; O'Neil CP; Hubbell JA
Nat Mater; 2008 Mar; 7(3):248-54. PubMed ID: 18246072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
